Iron Triangle Partners’s Zimmer Biomet ZBH Stock Holding History

Iron Triangle Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-221,598	Closed	-$34.6M	–	32
2021 Q2	$34.6M	Sell	221,598 -159,502	-42%	-$25.8M	3.56%	14
2021 Q1	$59.2M	Hold	381,100	–	–	7.53%	3
2020 Q4	$57M	Buy	381,100 +154,500	+68%	+$21.8M	7.39%	3
2020 Q3	$30M	Buy	226,600 +154,500	+214%	+$20.2M	6.69%	2
2020 Q2	$8.36M	Hold	72,100	–	–	2.1%	21
2020 Q1	$7.08M	Sell	72,100 -129,434	-64%	-$17M	2.74%	18
2019 Q4	$29.3M	Buy	+201,534	New	+$27.8M	7.76%	2

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Iron Triangle Partners's ZBH Position: Q3 2021 in Review

Iron Triangle Partners sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 221,598 shares — an estimated $34.6M sold.

Iron Triangle Partners first reported a position in ZBH in Q4 2019 and held it in 7 quarters. The position peaked at $59.2M in Q1 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Iron Triangle Partners reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Iron Triangle Partners sold 221,598 Zimmer Biomet shares in Q3 2021, an estimated $34.6M.
Iron Triangle Partners first reported a position in Zimmer Biomet in Q4 2019 and held it in 7 quarters.
Iron Triangle Partners's Zimmer Biomet position peaked at $59.2M in Q1 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Iron Triangle Partners's 13F filing for Q3 2021, filed 15 Nov 2021.